Vanda Pharmaceuticals (VNDA) Net Cash Flow (QoQ) (2010 - 2026)
Vanda Pharmaceuticals (VNDA) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Vanda Pharmaceuticals |
345.46 Mn |
143.15 Mn |
48.56 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-307.71% |
| Dec 31, 2025 |
237.36% |
| Sep 30, 2025 |
65.16% |
| Jun 30, 2025 |
-428.14% |
| Mar 31, 2025 |
366.65% |
| Dec 31, 2024 |
180.07% |
| Sep 30, 2024 |
88.63% |
| Jun 30, 2024 |
-108.38% |
| Mar 31, 2024 |
77.59% |
| Dec 31, 2023 |
-242.79% |
| Sep 30, 2023 |
116.30% |
| Jun 30, 2023 |
-193.16% |
| Mar 31, 2023 |
156.41% |
| Dec 31, 2022 |
1,056.23% |
| Sep 30, 2022 |
-1.75% |
| Jun 30, 2022 |
-158.89% |
| Mar 31, 2022 |
803.76% |
| Dec 31, 2021 |
124.19% |
| Sep 30, 2021 |
54.15% |
| Jun 30, 2021 |
-233.85% |
